Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bingzong Li
The Nuclear Factor (Erythroid-Derived 2)-Like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
Nuclear Factor (Erythroid-Derived 2)-Like 2 (NFE2L2; NRF2); Glial Fibrillary Acidic Protein (GFAP)
Science-Business eXchange
Nuclear Factor Erythroid-2 Related Factor 2 Nrf2 -Mediated Protein Quality Control in Cardiomyocytes
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Role of Nuclear Factor (Erythroid-Derived 2)-Like 2 Signaling for Effects of Fumaric Acid Esters on Dendritic Cells
Frontiers in Immunology
Allergy
Immunology
Nuclear Erythroid 2 P45-Related Factor 2 Inhibits the Maturation of Murine Dendritic Cells by Ragweed Extract
American Journal of Respiratory Cell and Molecular Biology
Respiratory Medicine
Pulmonary
Clinical Biochemistry
Cell Biology
Molecular Biology
Nuclear Factor Erythroid 2-Related Factor 2 and Heme Oxygenase-1 Protein Expression and Clinicopathological Features in Glioblastoma
Journal of Biosciences and Medicines
Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy
Journal of Diabetes Research
Endocrinology
Metabolism
Diabetes
Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance
Blood Cancer Journal
Oncology
Hematology
Lack of Association Between Nuclear Factor Erythroid-Derived 2-Like 2 Promoter Gene Polymorphisms and Oxidative Stress Biomarkers in Amyotrophic Lateral Sclerosis Patients
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma
BMC Cancer
Cancer Research
Oncology
Genetics
